Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC v. Enforma

This article was originally published in The Tan Sheet

Executive Summary

Commission, Enforma Natural Products jointly ask Los Angeles federal Judge Spencer Letts to appoint UCLA researcher David Heber, MD/PhD, as an expert to evaluate scientific issues involving Enforma's Fat Trapper Plus and Exercise In A Bottle weight-loss products. Parties will submit briefs April 17 on proposed issues to be evaluated by Heber if he receives court approval. FTC alleges Enforma has "blatantly disregarded" a May 2000 order by continuing to make unsubstantiated claims for the products. Heber is director of UCLA's botanical dietary supplements research center...

You may also be interested in...



FTC May File Contempt Charges Against Enforma Expert Witness, Lawyers

The FTC is considering filing a motion to hold Enforma Natural Products expert witness Harry Preuss, MD, Georgetown University School of Medicine, and outside counsel Edward Glynn and Gary Hailey in contempt of court for violating a May 2000 consent decree

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel